| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-07 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-07 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.59 | 2e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.53 | 7e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |